Skip to main content
SpringerLink
Log in

Cathepsin B and its endogenous inhibitors: the role in tumor malignancy

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

Several lysosomal proteinases including the cysteine proteinase cathepsin B have been implicated in malignant progression of tumors. Many investigators have demonstrated correlations between increased activity of cathepsin B and increased metastatic capability of animal tumors or malignancy of human tumors. Such increases in cathepsin B activity in malignant tumors may reflect alterations in synthesis, in activation and processing, and/or in intracellular trafficking and delivery as well as in the endogenous inhibitors of cathepsin B. Increases in mRNA transcripts for cathepsin B have been observed in both murine and human tumors and multiple transcripts for cathepsin B have been identified, but an association of multiple transcripts with malignancy has not been confirmed. Cathepsin B precursors found in human malignant ascites fluid do not possess mannose-rich carbohydrates suggesting that a defect in the post translational processing of carbohydrate moieties on tumor cathepsin B may be responsible for the release of cathepsin B observed in many tumor systems. However, the intracellular trafficking of cathepsin B responsible for its association with plasma membrane/endosomal systems and for its release willrequire further study as both latent, precursor forms of cathepsin B and native forms of cathepsin B are involved. We speculate that malignant tumor cells adherent to basement membrane are capable of forming a digestive microenvironment in which lysosomal proteinases such as cathepsin B function optimally, a microenvironment similar to that formed between adherent osteoclasts and bone. One of the endogenous cysteine proteinase inhibitors, stefin A, also is affected by malignancy. Reduced expression (mRNA and protein) of stefin A is found as well as a reduction in its inhibitory capacity against cysteine proteinases. The data to date at both the molecular and protein levels supporting a functional role(s) for cathepsin B and its endogenous inhibitors in cancer progression are only correlative. Experimental approaches utilizing well-defined model systems in conjunction with genetic manipulation of cathepsin B and its endogenous inhibitors are needed to provide convincing evidence that cathepsin B has an important role in cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Spyratos F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, Hacene K, Desplaces A, Rochefort H: An important marker predicting metastasis in primary breast cancer. Lancet (ii): 1115–1118, 1989

  2. Tandon A, Clark G, Chamness G, Chirgwin J, McGuire WL: Cathepsin D and prognosis in breast cancer. N Engl J Med 322: 297–302, 1990

    Google Scholar 

  3. Pietras RJ, Szego CM: Cathepsin D in breast cancer (Letter to editor). N Engl J Med 322: 1673–1674, 1990

    Google Scholar 

  4. Recklies AD, Poole AR: Proteolytic mechanisms of tissue destruction in tumor growth and metastasis. In: Weiss L, Gilbert HA (eds) Liver metastasis. GK Hall, Boston, 1982, pp 77–95

    Google Scholar 

  5. Sloane BF, Honn KV: Cysteine proteinases and metastasis. Cancer Metastasis Rev 3: 249–263, 1984

    Google Scholar 

  6. Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV: Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp Cell Biol 55: 209–224, 1987

    Google Scholar 

  7. Recklies AD: Biochemical aspects of cellular migration and invasion. Biorheology 23: 93–103, 1987

    Google Scholar 

  8. Sloane BF: Cathepsin B and cystatins: evidence for a role in cancer progression. Semin Cancer Biol 1: 137–152, 1990

    Google Scholar 

  9. Sloane BF, Krepela E, Lah TT: Regulation of lysosomal proteinases in neoplasia. In: Pretlow TG, Pretlow TP (eds) Aspects of the biochemistry and molecular biology of tumors. Academic Press, NY, in press

  10. Collela R, Denhardt D: Anti-cancer activities of naturally occurring cysteine proteinase inhibitors. In: Troll W, Kennedy A (eds) Proteinase inhibitors as cancer chemopreventive agents. Plenum Press, New York, in press.

  11. Willstatter R, Bamann E: Uber die proteasen der magenschleimhaut. Erste abhandlung uber die enzyme der leukocyten. Hoppe-Seylers Z Physiol Chem 180: 127–143, 1929

    Google Scholar 

  12. Kornfeld S, Mellman I: The biogenesis of lysosomes. Annu Rev Cell Biol 5: 483–525, 1989

    Google Scholar 

  13. Barrett AJ, Kirschke H: Cathepsin B, cathepsin H, cathepsin L. Meth in Enzymol 80: 535–561, 1981

    Google Scholar 

  14. Chan SJ, San Segundo B, McCormick MB, Steiner DF: Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proc Natl Acad Sci USA 83: 7721–7725, 1986

    Google Scholar 

  15. Hanewinkel H, Glossl J, Kresse H: Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. J Biol Chem 262: 12351–12355, 1987

    Google Scholar 

  16. Kominami E, Tsukahara T, Hara K, Katunuma N: Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages. FEBS Lett 231: 225–228, 1988

    Google Scholar 

  17. Hara K, Kominami E, Katunuma N: Effect of proteinase inhibitors on intracellular processing of cathepsin B, H and L in rat macrophages. FEBS Lett 231: 229–231, 1988

    Google Scholar 

  18. Nishimura Y, Kawabata T, Kato K: Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch Biochem Biophys 261: 64–71, 1988

    Google Scholar 

  19. Takahashi T, Dehdarani AH, Yonezawa S, Tang J: Porcine spleen cathepsin B is an exopeptidase. J Biol Chem 261: 9375–9381, 1986

    Google Scholar 

  20. Mason RW: Interaction of lysosomal cysteine proteinases with α2-macroglobulin: conclusive evidence for the endopeptidase activities of cathepsins B and H. Arch Biochem Biophys 273: 367–374, 1989

    Google Scholar 

  21. Rozhin J, Robinson D, Stevens MA, Lah TT, Honn KV, Ryan RE, Sloane BF: Properties of a plasma membraneassociated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. Cancer Res 47: 6620–6628, 1987

    Google Scholar 

  22. Kirschke H, Locnikar P, Turk V: Species variations amongst lysosomal cysteine proteinases. FEBS Letts 174: 123–127, 1984

    Google Scholar 

  23. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CJ, Tamai M, Hanada K: L-trans-epoxysuccinylleucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 201: 189–198, 1982

    Google Scholar 

  24. Green GDJ, Shaw E: Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. J Biol Chem 256: 1923–1928, 1981

    Google Scholar 

  25. Crawford C, Mason RW, Wikstrom P, Shaw E: The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B. Biochem J 253: 751–758, 1988

    Google Scholar 

  26. Kirschke H, Shaw E: Rapid inactivation of cathepsin L by Z-Phe-PheCHN2 and Z-Phe-AlaCHN2. Biochem Biophys Res Commun 101: 454–458, 1981

    Google Scholar 

  27. Shaw E: Peptidyl sulfonium salts. J Biol Chem 263: 2768–2772, 1988

    Google Scholar 

  28. Rich DH: Inhibitors of cysteine proteinases. In: Barrett AJ, Salvesen G (eds) Proteinase inhibitors. Elsevier, Amsterdam, 1986, pp 153–178

    Google Scholar 

  29. Demuth HU: Recent developments in inhibiting cysteine and serine proteases. J Enzym Inhib 3: 249–278, 1990

    Google Scholar 

  30. Smith RA, Coles PJ, Spencer RW, Copp LJ, Jones CS, Krantz A: Peptidyl O-acyl hydroxamates: potent new inactivators of cathepsin B. Biochem Biophys Res Commun 155: 1201–1206, 1988

    Google Scholar 

  31. Willenbrock F, Brocklehurst K: A general framework of cysteine-proteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and-161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Biochem J 227: 521–528, 1985

    Google Scholar 

  32. Lah TT, Buck MR, Honn KV, Crissman JD, Rao NC, Liotta LA, Sloane BF: Degradation of laminin by human tumor cathepsin B. Clin Exp Metastasis 7: 461–468, 1989

    Google Scholar 

  33. Mort JS, Recklies AD: Interrelationship of active and latent secreted human cathepsin B precursors. Biochem J 233: 57–63, 1986

    Google Scholar 

  34. Sloane BF, Dunn JR, Honn KV: Lysosomal cathepsin B: correlation with metastatic potential. Science 212: 1151–1153, 1981

    Google Scholar 

  35. Sloane BF, Honn KV, Sadler JG, Turner WA, Kimpson JJ, Taylor JD: Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res 42: 980–986, 1982

    Google Scholar 

  36. Ryan RE, Crissman JD, Honn KV, Sloane BF: Cathepsin B-like activity in viable tumor cells isolated from rodent tumors. Cancer Res 45: 3636–3641, 1985

    Google Scholar 

  37. Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV: Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci USA 83: 2483–2487, 1986

    Google Scholar 

  38. Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV: Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp Cell Biol 55: 209–224, 1987

    Google Scholar 

  39. Moin K, Rozhin J, McKernan TB, Sanders VJ, Fong D, Honn KV, Sloane BF: Enhanced levels of cathepsin B mRNA in murine tumors. FEBS Lett 244: 61–64, 1989

    Google Scholar 

  40. Keren Z, LeGrue SJ: Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction. Cancer Res 48: 1416–1421, 1988

    Google Scholar 

  41. Qian F, Bajkowski AS, Steiner DF, Chan SJ, Frankfater A: Expression of five cathepsins in murine melanomas of varving [sic] metastatic potential and normal tissues. Cancer Res 49: 4870–4875, 1989

    Google Scholar 

  42. Recklies AD, Poole AR, Mort JS: A cysteine proteinase secreted from human breast tumors is immunologically related to cathepsin B. Biochem J 207: 633–636, 1982

    Google Scholar 

  43. Mort JS, Leduc M, Recklies A: A latent thiol proteinase from ascitic fluid of patients with neoplasia. Biochim Biophys Acta 662: 173–180, 1981

    Google Scholar 

  44. Lah TT, Clifford JL, Helmer KM, Day NA, Moin K, Honn KV, Crissman JD, Sloane BF: Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim Biophys Acta 993: 63–73, 1989

    Google Scholar 

  45. Rozhin J, Gomez AP, Ziegler GH, Nelson KK, Chang YS, Fong D, Onoda JM, Honn KV, Sloane BF: Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res, 50: 6278–6284, 1990

    Google Scholar 

  46. Koppel P, Baici A, Keist R, Matzku S, Keller R: Cathepsin B like proteinase as a marker for tumor cell variants. Exp Cell Biol 52: 293–299, 1984

    Google Scholar 

  47. Recklies AD, Tiltman KJ, Stoker TAM, Poole AR: Secretion of proteinases from malignant and non-malignant human breast tissue. Cancer Res 40: 550–556, 1980

    Google Scholar 

  48. Murnane MJ: Cathepsin B expression in human colorectal carcinoma. Cancer Res, in press.

  49. Bernhard HP, Darlington, Ruddle FH: Evidence of liver phenotypes in cultured mouse hepatoma cells: synthesis and secretion of serum albumin. Dev Biol 35: 83–96, 1973

    Google Scholar 

  50. San Segundo B, Chan SJ, Steiner DF: Differences in cathepsin B mRNA levels in rat tissue suggest specialized functions. FEBS Lett 201: 251–256, 1986

    Google Scholar 

  51. Fong D, Calhoun DH, Hsieh W-T, Lee B, Wells RD: Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B. Proc Natl Acad Sci USA 83: 2909–2913, 1986

    Google Scholar 

  52. Qian F, Chan SJ, Bajkowski AS, Steiner DF, Frankfater A: Characterization of three cathepsin B mRNA transcripts in murine B16a melanoma. FASEB J 4: A1817, 1990

  53. Azuma T, Pals G, Mohandas TK, Couvreur JM, Taggart RT: Human gastric cathepsin E: predicted sequence, localization to chromosome 1 and sequence homology with other aspartic proteinases. J Biol Chem 264: 16748–16753, 1989

    Google Scholar 

  54. Pagano M, Dalet-Fumeron V, Engler R: The glycosylation state of the precursors of the cathepsin B-like proteinase from human malignant ascitic fluid: Possible implication in the secretory pathway of these proenzymes. Cancer Lett 45: 13–19, 1989

    Google Scholar 

  55. Pagano M, Capony F, Rochefort H: La pro-cathepsine D peut activer in vitro la pro-cathepsine B sécrétée par les cancers ovariens. CR Acad Sci Paris 309: 7–12, 1989

    Google Scholar 

  56. Lowy DR, Willumsen BM: New clue to ras lipid glue. Nature 341: 384–385, 1989

    Google Scholar 

  57. Chi L, Zhu M, Marks N: High affinity binding of rat brain cathepsin B to purified rat/bovine cerebral mannose 6-phosphate receptors. Biol Chem Hoppe-Seyler 371 suppl: 259–264, 1990

    Google Scholar 

  58. vanDongen JM, Willensen R, Ginns EI, Sips HJ, Tager JM, Barranger JA, Reuser AJJ: The subcellular localization of soluble and membrane bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study. Eur J Cell Biol 39: 179–189, 1985

    Google Scholar 

  59. Cavanaugh PG, Sloane BF, Bajkowski AS, Gasic GJ, Gasic TB, Honn KV: Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clin Exp Metastasis 1: 297–307, 1983

    Google Scholar 

  60. Rozhin J, Wade RL, Honn KV, Sloane BF: Membrane-associated cathepsin L: a role in metastasis of melanomas. Biochem Biophys Res Commun 164: 556–561, 1989

    Google Scholar 

  61. Jensen HK, Ledet T: Proteolysis of arterial basement membrane containing different amounts of carbohydrates. Thromb Res 44: 47–53, 1986

    Google Scholar 

  62. Maciewicz RA, Wardale RJ, Etherington DJ, Paraskeva C: Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int J Cancer 43: 478–486, 1989

    Google Scholar 

  63. Ohsawa T, Higashi T, Tsuji T: The secretion of high molecular weight cathepsin B from cultured human liver cancers. Acta Med Okayama 43: 9–15, 1989

    Google Scholar 

  64. Goldberg DE, Gabel CA, Kornfeld S: Studies of the biosynthesis of the mannose 6-phosphate receptor in receptor-positive and-deficient cell lines. J Cell Biol 97: 1700–1706, 1983

    Google Scholar 

  65. Mainferme F, Wattiaux R, vonFigura K: Synthesis, transport and processing of cathepsin C in Morris hepatoma 7777 cells and rat hepatocytes. Eur J Biochem 153: 211–216, 1985

    Google Scholar 

  66. Prence EM, Dong J, Sahagian GG. Modulation of the transport of a lysosomal enzyme by PDGF. J Cell Biol 110: 319–326, 1990

    Google Scholar 

  67. Erdel M, Trefz G, Spiess E, Habermaas S, Spring H, Lah T, Ebert W: Localization of cathepsin B in two human lung cancer cell lines. J Histochem Cytochem (in press)

  68. Krepela E, Bartek J, Skalkova D: Cytochemical and biochemical evidence of cathepsin B in malignant, transformed and normal breast epithelial cells. J Cell Sci 87: 145–154, 1987

    Google Scholar 

  69. Barrett AJ: The cystatins: a new class of peptidase inhibitors. Trends Biochem Sci 12: 193–196, 1987

    Google Scholar 

  70. Muller-Esterl W, Iwanaga S, Nakanishi S: Kininogens revisited. Trends Biochem Sci 11: 336–339, 1986

    Google Scholar 

  71. Green GDJ, Kembhavi AA, Davies ME, Barrett AJ: Cystatin-like cysteine proteinase inhibitors from human liver. Biochem J 218: 939–946, 1984

    Google Scholar 

  72. Nicklin MJH, Barrett AJ: Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin. Biochem J 223: 245–253, 1984

    Google Scholar 

  73. Hawley-Nelson P, Roop DR, Cheng CK, Krieg TM, Yuspa SH: Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis. Mol Carcinogenesis 1: 202–211, 1988

    Google Scholar 

  74. Rinne A, Jarvinen M, Rasanen O, Hopsu-Havu VK: Acid and neutral cysteine proteinase inhibitor in normal uterine portio and in squamo-epithelial metaplasia, dysplasias and infiltrative carcinoma of the uterine portio. Exp Pathol 26: 67–70, 1984

    Google Scholar 

  75. Kyllonen AP, Jarvinen M, Hopsu-Havu VK, Dorn A, Rasanen O, Larmi T, Rinne A: The behaviour of small molecular cysteine proteinase inhibitors in lung cancers and in surrounding tissue. Acta Histochem 74: 109–113, 1984

    Google Scholar 

  76. Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A, Jensson O: A mutation in the cystatin C gene causes hereditary brain hemorrhage. Lancet 1988: 603–604, 1988

    Google Scholar 

  77. Liotta LA, Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin Cancer Biol 1: 99–106, 1990

    Google Scholar 

  78. Redhead S: Osteoclastic bone resorption: all hands to the proton pump. J NIH Res 2: 57–60, 1990

    Google Scholar 

  79. Baron R: Molecular mechanism of bone resorption by osteoclasts. Anat Rec 224: 317–324, 1989

    Google Scholar 

  80. Canalis E, McCarthy T, Centrella M: Growth factors and the regulation of bone remodeling. J Clin Invest 81: 277–281, 1988

    Google Scholar 

  81. Kornfeld S: Lysosomal enzyme targeting. Biochem Soc Trans 18: 367–374, 1990

    Google Scholar 

  82. Kornfeld S: Trafficking of lysosomal enzymes. FASEB J 1: 462–468, 1987

    Google Scholar 

  83. Roederer M, Bowser R, Murphy RF: Kinetics and temperature dependence of exposure of endocytosed material to proteolytic enzymes and low pH: evidence for a maturation model for the formation of lysosomes. J Cell Physiol 131: 200–209, 1987

    Google Scholar 

  84. Roederer M, Barry JR, Wilson RB, Murphy RF: Endosomes can undergo an ATP-dependent density increase in the absence of dense lysosomes. Eur J Cell Biol 51: 229–234, 1990

    Google Scholar 

  85. Silver IA, Murrills RJ, Etherington DJ: Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175: 266–276, 1988

    Google Scholar 

  86. Grossi IM, Hatfield JS, Fitzgerald LA, Newcombe M, Taylor JD, Honn KV: Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions. FASEB J 2: 2385–2395, 1988

    Google Scholar 

  87. Ghelsen KR, Argraves WS, Pierschbacher MD, Ruoslahti E: Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol 106: 925–930, 1988

    Google Scholar 

  88. Kramer RH, McDonald KA, Crowley E, Ramos DM, Damsky CH: Melanoma cell adhesion to basement membrane mediated by integrin-related complexes. Cancer Res 49: 393–402, 1989

    Google Scholar 

  89. Skudlarek MD, Swank RT: Turnover of two lysosomal enzymes in macrophages. J Biol Chem 256: 10137–10144, 1981

    Google Scholar 

  90. Reilly JJ, Mason RW, Chen P, Joseph LJ, Sukhatme VP, Yee R, Chapman HA: Synthesis and processing of cathepsin L, an elastase, by human alveolar macrophages. Biochem J 257: 493–498, 1989

    Google Scholar 

  91. Sloane BF, Ryan RE, Rozhin J, Lah TT, Crissman JD, Honn KV: Cathepsin B: A proteinase linked to metastasis? In: Tschesch H (ed) Proteinases in inflammation and tumor invasion. deGruyter, Berlin, 1986, pp 93–106

    Google Scholar 

  92. Achkar C, Gong Q, Frankfater A, Bajkowski AS: Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Molony murine sarcoma virus transformed BALB/3T3 fibroblasts. J Biol Chem 265: 13650–13654, 1990

    Google Scholar 

  93. Dong J, Prence EM, Sahagian GG: Mechanism for selective secretion of a lysosomal proteinase by transformed mouse fibroblasts. J Biol Chem 264: 7377–7383, 1989

    Google Scholar 

  94. Dong J, Sahagian GG: Basis for low affinity binding of a lysosomal cysteine protease to the cation-independent mannose 6-phosphate receptor. J Biol Chem 265: 4210–4217, 1990

    Google Scholar 

  95. Heuser J: Changes in lysosomal shape and distribution correlated with changes in cytoplasmic pH. J Cell Biol 108: 855–864, 1989

    Google Scholar 

  96. Krepela E, Vesely P, Chaloupkova A, Zicha D, Urbanec P, Rasnick D, Vicar J: Cathepsin B in cells of two rat sarcomas with different rates of spontaneous metastasis. Neoplasma 36: 529–540, 1989

    Google Scholar 

  97. Murphy RF: Processing of endocytosed material. Advan Cell Biol 2: 159–180, 1988

    Google Scholar 

  98. Baricos WH, Zhou Y, Mason RW, Barrett AJ: Human kidney cathepsins B and L. Biochem J 252: 301–304, 1988

    Google Scholar 

  99. Gingras MC, Jarolim L, Finch J, Bowden GT, Wright JA, Greenberg AH: Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts. Cancer Res 50: 4061–4066, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Wayne State University, 48201, Detroit, MI, USA

    Bonnie F. Sloane, Kamiar Moin, Evzen Krepela & Jurij Rozhin

Authors
  1. Bonnie F. Sloane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kamiar Moin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Evzen Krepela
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jurij Rozhin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sloane, B.F., Moin, K., Krepela, E. et al. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Metast Rev 9, 333–352 (1990). https://doi.org/10.1007/BF00049523

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00049523

Key words

Search

Navigation